Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic white children: The Corpus Christi Child Heart Study

Circulation

Volumn 96, Issue 12, 1997, Pages 4319-4325

  Batey, Lyn Steffen ^a   Goff Jr , David C ^b   Tortolero, Susan R ^b   Nichaman, Milton Z ^b   Chan, Wenyaw ^b   Chan, Frances A ^b   Grunbaum, Joanne ^b   Hanis, Craig L ^b   Labarthe, Darwin R ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

Coronary disease; Insulin; Risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CAUCASIAN; CHILD; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEXICO; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SYNDROME; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 0031439406     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.12.4319     Document Type: Article

References (51)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514-1520.
3. Taskinen M-R. Strategies for the diagnosis of metabolic syndrome. Curr Opin Lipid. 1993;4:434-443.
4. Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ. 1988;297:960-963.
5. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and African-Americans: the Atherosclerosis Risk in Communities baseline study. Diabetes Care. 1996;19:414-418.
6. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
7. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
8. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia, the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-422.
9. Arnesen H. Introduction, the metabolic cardiovascular syndrome. J Cardiovasc Phamacol. 1992;20(suppl 8):S1-S4.
10. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, and atherothrombogenic syndrome. J Cardiovasc Pharmacol. 1992;20(suppl 8): S5-S10.
11. Reaven GM. Syndrome X 6 years later. J Intern Med. 1994;236(suppl 736):13-22.
12. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol. 1992;136:12-22.
13. Reaven GM. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism. 1992;41(suppl 1):16-19.
14. Zavaroni I, Honora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven GM. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320:702-706.
15. Laakso M. Dyslipidaemias, insulin resistance and atherosclerosis. Ann Med. 1992;24:505-509.
16. Hanis CL, Ferrell RE, Barton SA, Aguilar L, Garza-Ibarra A, Tulloch BR, Garcia CA, Schull WJ. Diabetes among Mexican Americans in Starr County, Texas. Am J Epidemiol. 1983;118:659-672.
17. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care. 1991;14:102-108.
18. Haffner SM. Hyperinsulinemia as a possible etiology for the high prevalence of non-insulin dependent diabetes in Mexican Americans. Diabetes Metab. 1987;13:55-62.
19. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC. Methods and prevalence of noninsulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol. 1989;129:295-311.
20. Goff DC, Varas C, Ramsey DJ, Wear ML, Labarthe DR, Nichaman MZ. Mortality after hospitalization for myocardial infarction among Mexican Americans and non-Hispanic whites: the Corpus Christi Heart Project. Ethn Dis. 1993;3:55-63.
21. Goff DC, Ramsey DJ, Labarthe DR, Nichaman MZ. Greater casefatality after myocardial infarction among Mexican Americans and women than among non-Hispanic whites and men: the Corpus Christi Heart Project. Am J Epidemiol. 1994;139:474-483.
22. Flegal KM, Ezzati TM, Harris MI, Haynes SG, Juarez RZ, Knowler WC, Perez-Stable EJ, Stern MP. Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care. 1991;14:628-638.
23. Harris MI. Epidemiological correlates of NIDDM in Hispanics, whites and blacks in the US population. Diabetes Care. 1991;14(suppl 3):639-648.
24. Stern MP, Haffner SM. Type II diabetes and its complications in Mexican Americans. Diabetes Metab Rev. 1990;6:29-45.
25. Hanis CL, Hewett-Emmett D, Bertin TK, Schull WJ. Origins of US Hispanics: implications for diabetes. Diabetes Care. 1991;14(suppl 3):618-27.
26. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137:959-965.
27. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LTH, Bennett PH, Knowler WC. Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM. Diabetologia. 1994;37:617-623.
28. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
29. 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand. 1985;701(suppl):38-52.
30. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991;34:356-361.
31. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prcdiabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893-2898.
32. Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, Bergman RN. Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism. 1990;39:842-847.
33. King H, Finch C, Zimmet P, Alpers M. Plasma glucose and insulin responses in young Papua New Guineans (aged 10-19 years). Diabetes Res Clin Prac. 1990;10:153-159.
34. Zimmet PZ, Collins VR, Dowse GK, Knight LT. Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:534-541.
35. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87:269-272.
36. ++ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
37. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentifuge. Clin Chem. 1972;18:499-502.
38. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice Hall;1988.
39. Dunteman GH. Principal Components Analysis. Newbury, Calif: Sage Publications; 1989.
40. Stata for Windows, Release 4.0. College Station, Tex: Stata Corp; 1995.
41. Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Freedman DS, Berenson GS. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism. 1986;35:441-446.
42. Srinivasan SR, Bao W, Berenson GS. Coexistence of increased levels of adiposity, insulin, and blood pressure in a young adult cohort with elevated very-low density lipoprotein cholesterol: the Bogalusa Heart Study. Metabolism. 1993;42:170-176.
43. Ronnemaa T, Knip M, Lautala P, Viikari J, Uhari M, Leino A, Kaprio EA, Salo MK, Dahl M, Nuutinen M, Pesonen E, Pietikainen M, Akerblom HK. Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med. 1991;23:67-72.
44. Manolio TA, Savage PJ, Burke GL, Liu K, Wagenknecht LE, Sidney S, Jacobs DR, Roseman JM, Donahue RP, Oberman A. Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA Study. Arteriosclerosis. 1990;10:430-436.
45. Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch Intern Med. 1995;155:190-196.
46. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: the Bogalusa Heart Study. Arch Intern Med. 1994;154:1842-1847.
47. Webber LS, Osganian V, Luepker RV, Feldman HA, Stone EJ, Elder JP, Perry CL, Nader PR, Parcel GS, Broyles SL, McKinlay SM, for the CATCH Study Group. Cardiovascular risk factors among third grade children in four regions of the United States. Am J Epidemiol. 1995;141:428-439.
48. Webber LS, Harsha DW, Phillips GT, Srvinivasan SR, Simpson JW, Berenson GS. Cardiovascular risk factors in Hispanic, white, and black children: the Brooks County and Bogalusa Heart studies. Am J Epidemiol. 1991;133:704-714.
49. Greaves KA, Puhl J, Baranowski T, Gruben D, Seale D. Ethnic differences in anthropometric characteristics of young children and their parents. Hum Biol. 1989;61:459-477.
50. Burtis CA, Ashwood ER, Eds. Tietz Fundamentals of Clinical Chemistry. 4th ed. Philadelphia, Pa: WB Saunders; 1991.
51. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb. 1994;14:1940-1945.